CHF (3/6) Flashcards
systolic vs diastolic HF
systolic LV, reduced EF
diastolic preserved LV EF
remodeling
adaptation to reduced CO
cardiac dilation, ^sympathetic tone, water retention and ^BV, natriuretic peptides
remodeling neurohormone systems
Renin angiotensin aldosterone, sympathetic nervous
CHF s/s
s3 gallop, cool pale cyanotic extremities, crackles, vBreath sounds (effusion), ^jugular venous pressure, LE edema, ascites, hepatomegaly, splenomegaly, displaced PMI
CHF diagnostics
echo (syst vs dias, valve disease), xray (cephalization pulm vessels, Kerley B lines), EKG (ischemic heart disease)
BNP level of exacerbation
100+
CHF tx
diuretics
(mod) Thiazide = vK( ^dig toxicity), w minimal edema
(large) Loop diuretics=vK(^dig toxicity), hypotension, work when gfr is low, for severe HF
(scant) K sparing diuretics-counteract K loss by other meds (vRisk for Dig tox), risk ^K*caution w ARBs/ACEi (dc diuretic)
which diuretic prolongs survival, why
spironolaction bc blocks aldosterone receptors (not bc diuresis)
ACEi AE
vBP, ^K, cough, angioedema, renal failure (bilateral renal artery stenosis) fetal injury
ARB
^LV EF, vHF sx, ^exercise tolerance, vHospitalization, vMortality
ARNI
angiotensin receptor blocker + neprolysin inhibitor
entresto
^natiuretic peptides, vAE of RAAS
used in place w ace/arb NOT w/
DRI
direct renin inhibitor
HTN only, not HF
B Blockers
1st line
protect from sympathetic stimulation and dysrhythmias
^LV EF, ^survival
AE: fluid retention, worse HF, fatigue, hypotension, vHR, heart block
Ivabradine
for stable chronic HF
EF <35%
NSR
70bpm on highest b blocker w/o improvement
Vericiguat
after hospitalization/outpt diuresis for HF <45%,
AE: vBP, xPD5i, xPregnant